INS and metabolic dysfunction-associated steatotic liver disease: These disruptions in adipose tissue function not only contribute to the prevalence of non-alcoholic fatty liver disease in obese, insulin-resistant, and diabetic individuals but also impact insulin secretion by inhibiting β-cell potassium channels and altering ATP production [18].